Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1166588 NEW YORK, NY

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$41,396,142
+$19,532,395 QoQ
Shares Held
528,889
+56.3% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#52
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Derivatives in HALO

reported options exposure · as of Dec 31, 2024
CallValue
$4,781
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. HALO ranks #26 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,396,142 528,889
2026-03-31 $21,863,747 338,291
2025-12-31 $42,636,501 633,529
2025-09-30 $56,984,153 776,986
2025-06-30 $13,963,780 268,431
2025-03-31 $28,252,324 442,757
2024-12-31 $3,363,146 70,344
2024-12-31 $4,781 100
2024-09-30 $2,375,173 41,495
2024-06-30 $6,762,084 129,146
2024-03-31 $12,075,451 296,840
2023-12-31 $8,157,478 220,711
2023-09-30 $11,867,823 310,676
2023-06-30 $8,593,821 238,254
2023-03-31 $4,017,473 105,197
2022-12-31 $12,023,425 211,308
2022-09-30 $6,085,640 153,911
2022-06-30 $2,633,180 59,845
2022-06-30 $13,200 300
2022-03-31 $1,810,193 45,391
2021-12-31 $2,193,495 54,551
2021-12-31 $51,589 1,283
2021-09-30 $4,024,146 98,922
2021-09-30 $8,136 200
2021-06-30 $4,291,789 94,512
2021-03-31 $4,620,627 110,833
2020-12-31 $7,206,202 168,724
2020-09-30 $4,531,171 172,419
2020-06-30 $4,128,016 153,973
2020-03-31 $9,960,433 553,665